Getagraph.com logo
S&P 500
(0.31%) 5 115.57 points
Dow Jones
(0.31%) 38 360 points
Nasdaq
(0.33%) 15 981 points
Oil
(-0.94%) $83.06
Gas
(5.51%) $2.03
Gold
(0.36%) $2 355.60
Silver
(0.41%) $27.65
Platinum
(4.01%) $959.05
USD/EUR
(-0.23%) $0.933
USD/NOK
(-0.38%) $10.98
USD/GBP
(-0.55%) $0.796
USD/RUB
(1.69%) $93.43

リアルタイムの更新： Merrimack Pharmaceuticals [MACK]

取引所: NASDAQ セクター: Healthcare 産業: Biotechnology
Upcoming Earnings Alert

3 days till quarter result
(bmo 2024-05-02)

Expected move: +/- 5.19%

最終更新日時30 4月 2024 @ 01:42
25% discount on Stockinvest.us - Use code: Podcast

0.07% $ 14.74

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:42):

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Stats
本日の出来高 28 819.00
平均出来高 132 937
時価総額 214.20M
EPS $0 ( 2024-03-14 )
次の収益日 ( $0 ) 2024-05-02
Last Dividend $0.500 ( 2019-12-13 )
Next Dividend $0 ( N/A )
P/E -184.25
ATR14 $0.00500 (0.03%)
Insider Trading
Date Person Action Amount type
2023-12-28 Andersen Eric Buy 857 Common Stock
2023-12-26 Andersen Eric Buy 48 693 Common Stock
2023-12-07 Andersen Eric Buy 76 384 Common Stock
2023-12-07 Andersen Eric Buy 24 666 Common Stock
2023-11-17 Andersen Eric Buy 235 Common Stock
INSIDER POWER
99.80
Last 100 transactions
Buy: 1 159 920 | Sell: 7 000

ボリューム 相関

長: -0.02 (neutral)
短: -0.40 (neutral)
Signal:(57.741) Neutral

Merrimack Pharmaceuticals 相関

10 最も正の相関
10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Merrimack Pharmaceuticals 相関 - 通貨/商品

The country flag -0.07
( neutral )
The country flag -0.41
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.44
( neutral )

Merrimack Pharmaceuticals 財務諸表

Annual 2023
収益: $0
総利益: $0 (0.00 %)
EPS: $-0.0826
FY 2023
収益: $0
総利益: $0 (0.00 %)
EPS: $-0.0826
FY 2022
収益: $0
総利益: $-445 000 (0.00 %)
EPS: $-0.110
FY 2021
収益: $0.00
総利益: $0.00 (0.00 %)
EPS: $-0.180

Financial Reports:

No articles found.

Merrimack Pharmaceuticals Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A)

Merrimack Pharmaceuticals Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A
Information
First Dividend $8.30 2017-05-30
Last Dividend $0.500 2019-12-13
Next Dividend $0 N/A
Payout Date 2019-12-23
Next Payout Date N/A
# dividends 3 --
Total Paid Out $10.30 --
Avg. Dividend % Per Year 0.00% --
Score 0.23 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
 (2025-09-03)
$0 Estimate 0.00 %
Dividend Stability
0.02 Very Bad
Dividend Score
0.23
Pay Frequency
Sporadic
Yearly Payout
Year Amount Yield
2017 $8.30 26.40%
2018 $0 0.00%
2019 $1.997 62.60%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM01.50000[0 - 0.5]
returnOnAssetsTTM-0.05241.200-1.746-2.10[0 - 0.3]
returnOnEquityTTM-0.05311.500-1.701-2.55[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM43.500.80010.008.00[1 - 3]
quickRatioTTM42.800.80010.008.00[0.8 - 2.5]
cashRatioTTM13.581.50010.0010.00[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM-0.1062.00-0.0354-0.0708[0 - 30]
freeCashFlowPerShareTTM-0.1062.00-0.0531-0.106[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM01.000-3.33-3.33[0.2 - 0.8]
operatingProfitMarginTTM01.000-2.00-2.00[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score0.695

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-210.151.000-10.000[1 - 100]
returnOnEquityTTM-0.05312.50-1.093-2.55[0.1 - 1.5]
freeCashFlowPerShareTTM-0.1062.00-0.0354-0.106[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-0.1062.00-0.0354-0.0708[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM01.500-3.330[0.5 - 2]
operatingCashFlowSalesRatioTTM01.000-2.500[0.1 - 0.5]
Total Score-1.537

Merrimack Pharmaceuticals

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。